Intellia Therapeutics Statistics
Total Valuation
NTLA has a market cap or net worth of $1.68 billion. The enterprise value is $1.17 billion.
Important Dates
The next estimated earnings date is Thursday, May 7, 2026, before market open.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NTLA has 118.13 million shares outstanding. The number of shares has increased by 9.64% in one year.
| Current Share Class | 118.13M |
| Shares Outstanding | 118.13M |
| Shares Change (YoY) | +9.64% |
| Shares Change (QoQ) | +5.20% |
| Owned by Insiders (%) | 2.11% |
| Owned by Institutions (%) | 86.89% |
| Float | 111.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.89 |
| Forward PS | 26.96 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 17.33 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.08, with a Debt / Equity ratio of 0.14.
| Current Ratio | 5.08 |
| Quick Ratio | 4.42 |
| Debt / Equity | 0.14 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -53.48% and return on invested capital (ROIC) is -29.85%.
| Return on Equity (ROE) | -53.48% |
| Return on Assets (ROA) | -27.11% |
| Return on Invested Capital (ROIC) | -29.85% |
| Return on Capital Employed (ROCE) | -59.74% |
| Weighted Average Cost of Capital (WACC) | 14.41% |
| Revenue Per Employee | $179,499 |
| Profits Per Employee | -$1.09M |
| Employee Count | 377 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +92.44% in the last 52 weeks. The beta is 1.99, so NTLA's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | +92.44% |
| 50-Day Moving Average | 13.06 |
| 200-Day Moving Average | 12.92 |
| Relative Strength Index (RSI) | 59.15 |
| Average Volume (20 Days) | 3,139,039 |
Short Selling Information
The latest short interest is 38.95 million, so 32.97% of the outstanding shares have been sold short.
| Short Interest | 38.95M |
| Short Previous Month | 39.44M |
| Short % of Shares Out | 32.97% |
| Short % of Float | 34.79% |
| Short Ratio (days to cover) | 9.89 |
Income Statement
In the last 12 months, NTLA had revenue of $67.67 million and -$412.69 million in losses. Loss per share was -$3.81.
| Revenue | 67.67M |
| Gross Profit | -256.78M |
| Operating Income | -440.99M |
| Pretax Income | -412.69M |
| Net Income | -412.69M |
| EBITDA | -431.22M |
| EBIT | -440.99M |
| Loss Per Share | -$3.81 |
Full Income StatementBalance Sheet
The company has $449.88 million in cash and $93.33 million in debt, with a net cash position of $511.81 million or $4.33 per share.
| Cash & Cash Equivalents | 449.88M |
| Total Debt | 93.33M |
| Net Cash | 511.81M |
| Net Cash Per Share | $4.33 |
| Equity (Book Value) | 671.39M |
| Book Value Per Share | 5.77 |
| Working Capital | 423.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$394.74 million and capital expenditures -$1.13 million, giving a free cash flow of -$395.87 million.
| Operating Cash Flow | -394.74M |
| Capital Expenditures | -1.13M |
| Depreciation & Amortization | 9.77M |
| Net Borrowing | n/a |
| Free Cash Flow | -395.87M |
| FCF Per Share | -$3.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -651.67% |
| Pretax Margin | -609.85% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NTLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.64% |
| Shareholder Yield | -9.64% |
| Earnings Yield | -24.50% |
| FCF Yield | -23.50% |
Analyst Forecast
The average price target for NTLA is $20.45, which is 43.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $20.45 |
| Price Target Difference | 43.41% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 104.22% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NTLA has an Altman Z-Score of -1.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.19 |
| Piotroski F-Score | 3 |
